BPC-157 vs Wolverine Blend
Tissue Repair
BPC-157
Synthetic pentadecapeptide derived from a gastric juice protein, widely studied for cytoprotection and angiogenic signaling.
Tissue Repair
Wolverine Blend
Co-formulated pentadecapeptide and thymosin beta-4 fragment, the two most frequently co-administered compounds in tissue-repair literature, supplied in a single vial.
Side by side
| Dimension | BPC-157 | Wolverine Blend |
|---|---|---|
| Molecular weight | 1419.53 g/mol | 1419.53 g/mol |
| Size class | short peptide | short peptide |
| CAS number | 137525-51-0 | 137525-51-0 / 77591-33-4 |
| Research area | repair | repair |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val / Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES |
| Available sizes | 5mg, 10mg | 10mg |
| Entry price | $39 | $69 |
| Cost per mg | $6.90 | $6.90 |
Mechanism
BPC-157
BPC-157 is a synthetic 15-amino-acid sequence corresponding to a partial fragment of body protection compound, a protein identified in human gastric juice. It is notably stable in gastric acid, a property unusual among peptides of comparable size and one that has made it a frequent subject of oral-administration studies in rodent models. The published literature is dominated by a single research group, which is a genuine methodological caveat worth noting when evaluating the evidence base.
Wolverine Blend
This blend combines BPC-157, a synthetic pentadecapeptide derived from a gastric juice protein, with TB-500, a synthetic fragment of thymosin beta-4. The two are the most frequently co-administered pair in the repair literature because they act through entirely different mechanisms: BPC-157 is studied for angiogenic signaling and cytoprotection, while TB-500 is studied for actin sequestration and cell migration. Co-formulation removes a reconstitution step; it is not a claim of synergy, and the underlying evidence for each compound remains separate.
Evidence quality
Mechanism is not the same as evidence. Where we have assessed the literature, the verdict is stated plainly.
BPC-157
Evidence base: substantial volume, narrow provenance. Weight accordingly and prefer independently replicated findings where they exist.
Full research reference →Research applications
BPC-157
- Angiogenesis and VEGFR2 signaling pathway studies
- Tendon and ligament fibroblast migration assays
- Gastrointestinal mucosal integrity research in rodent models
- Nitric oxide system interaction studies
Wolverine Blend
- Comparative angiogenesis and cell-migration assays
- Tendon and ligament repair models
- Actin-sequestration versus cytoprotection pathway separation
- Co-administration protocol design
Common questions
What is the difference between BPC-157 and Wolverine Blend?
BPC-157 is synthetic pentadecapeptide derived from a gastric juice protein, widely studied for cytoprotection and angiogenic signaling. Wolverine Blend is co-formulated pentadecapeptide and thymosin beta-4 fragment, the two most frequently co-administered compounds in tissue-repair literature, supplied in a single vial. They differ in molecular weight (1419.53 vs 1419.53 g/mol) and in the pathways they are studied against.
Which is more cost-effective per milligram, BPC-157 or Wolverine Blend?
BPC-157 is lower at approximately $6.90 per milligram at its best tier, against $6.90 for the other. Cost per milligram is only meaningful relative to the concentrations a given protocol requires, since these compounds are not used at comparable masses.
Can BPC-157 and Wolverine Blend be studied together?
Combination designs appear in the published literature for a number of these compounds. Whether it is appropriate for a given protocol depends entirely on the model and endpoint. We supply research compounds and do not provide protocol guidance — consult the primary literature for your specific model.
How should BPC-157 and Wolverine Blend be stored?
Store lyophilized powder at -20°C protected from light. Reconstituted solution stable at 2-8°C for up to 30 days. For Wolverine Blend: Store lyophilized powder at -20°C protected from light. Reconstituted solution stable at 2-8°C for up to 30 days.
Which has the stronger evidence base?
BPC-157 — Evidence base: substantial volume, narrow provenance. Weight accordingly and prefer independently replicated findings where they exist. Where we have not published a formal evidence assessment, treat the literature as requiring your own appraisal.
All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
Comparison generated from Lyra Vital catalog data. Every specification is reconciled against the certificate of analysis for the shipped batch.